Boston Scientific Corporation reported preliminary unaudited sales results for the fourth quarter and year ended December 31, 2018. For the quarter, the company’s net sales were $2.56 billion compared to $2.41 billion a year ago. For the year, the company’s net sales were $9.82 billion compared to $9.05 billion a year ago.